BCM
GILD icon

Beck Capital Management’s Gilead Sciences GILD Stock Holding History

Beck Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-21,220
Closed -$1.95M – 114
2016
Q1 		$1.95M Buy
21,220
+16,975
+400% +$1.53M 1.34% 30
2015
Q4 		$429K Buy
+4,245
New +$442K 0.25% 74
2015
Q3 		– Sell
-6,985
Closed -$818K – 120
2015
Q2 		$818K Buy
6,985
+100
+1% +$10.9K 0.44% 62
2015
Q1 		$676K Sell
6,885
-1,365
-17% -$139K 0.39% 68
2014
Q4 		$778K Buy
8,250
+85
+1% +$8.79K 0.45% 61
2014
Q3 		$864K Buy
8,165
+1,700
+26% +$166K 0.61% 54
2014
Q2 		$536K Buy
6,465
+2,705
+72% +$211K 0.36% 90
2014
Q1 		$277K Buy
+3,760
New +$295K 0.21% 121

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Beck Capital Management's GILD Position: Q2 2016 in Review

Beck Capital Management sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 21,220 shares — an estimated $1.95M sold.

Beck Capital Management first reported a position in GILD in Q1 2014 and held it in 8 quarters. The position peaked at $1.95M in Q1 2016. 1,596 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

  • Beck Capital Management reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
  • Beck Capital Management sold 21,220 Gilead Sciences shares in Q2 2016, an estimated $1.95M.
  • Beck Capital Management first reported a position in Gilead Sciences in Q1 2014 and held it in 8 quarters.
  • Beck Capital Management's Gilead Sciences position peaked at $1.95M in Q1 2016.
  • 1,596 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Beck Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.